We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Long Covid

News List

Long COVID May Qualify as a Disability: Biden drugs
July 28, 2021
Serious "long COVID" symptoms could qualify as a disability and make patients eligible for federal assistance, President Joe Biden said Monday.
"Long COVID": More than a quarter of COVID-19 patients still symptomatic after 6 months worldpharmanews
July 14, 2021
In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight months.
Long COVID Dramatically Increases Cases Of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome prnewswire
April 20, 2021
As Long COVID brings renewed attention to the debilitating and chronic illness known as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a record number of advocates are virtually gathering on Capitol Hill for Solve M.E.'s 5th Annual ...
NIHR review identifies long-term effects of COVID-19 pharmatimes
October 16, 2020
A review from the National Institute for Health Research will analyse the evidence around ongoing COVID-19 symptoms, otherwise referred to as ‘Long Covid’.